  |
Helicos BioSciencesHelicos BioSciences is a life-science company committed to developing instruments and reagents for the high speed sequencing of single DNA and RNA molecules. High speed sequencing is a breakthrough tool for solving many important and difficult problems in biology and medicine. Helicos BioSciences’ technology will allow cancer researchers to fully and accurately characterize the cancer genome on tens of thousands of tumors, thereby elucidating the full range of molecular alterations which cause cancer, leading to a new era in cancer diagnosis and therapy. Recent NewsHelicos BioSciences Announces Shipment of the World's First Single Molecule DNA SequencerHelicos BioSciences Announces First Order for the Helicos(TM) Genetic Analysis PlatformHelicos BioSciences Appoints Dr. Elisabeth Allison to Board of DirectorsHelicos BioSciences Announces MicroRNA Collaboration with miRNA ExpertHelicos BioSciences Enters into $20 Million Credit Facility with GE Healthcare Financial ServicesHelicos Biosciences Prices Initial Public OfferingHelicos BioSciences Files Registration Statement for Initial Public Offering of Common Stock |
 CEOStan LapidusContact InfoOne Kendall SquareBuilding 700 Cambridge, Massachusetts 02139 Phone: 617-264-1800 Fax: 617-264-1700 Key LinksWebsiteJobs Info Highland Team Bob Higgins
 Corey Mulloy
|